Carisma Therapeutics Inc. Variable Lease, Cost
Carisma Therapeutics Inc. reported Variable Lease, Cost of $115.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-11-12
- Carisma Therapeutics Inc. variable lease, cost for the quarter ending 2025-09-30 was -$94.00K, a 197.92% decline year-over-year.
- Carisma Therapeutics Inc. variable lease, cost for the quarter ending 2025-06-30 was $94.00K, a 53.00% decline year-over-year.
- Carisma Therapeutics Inc. variable lease, cost for the quarter ending 2025-03-31 was $115.00K, a 75.64% decline year-over-year.
- Carisma Therapeutics Inc. variable lease, cost for the quarter ending 2024-12-31 was $303.00K, a 41.39% decline year-over-year.
- Carisma Therapeutics Inc. variable lease, cost for fiscal 2024 was $1.07M, a 38.20% decline from fiscal 2023.
- Carisma Therapeutics Inc. variable lease, cost for fiscal 2023 was $1.73M, a 88.37% increase from fiscal 2022.
- Carisma Therapeutics Inc. variable lease, cost for fiscal 2022 was $920.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $115.00K 10-Q · filed 2025-11-12 | $418.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $209.00K 10-Q · filed 2025-08-07 | $512.00K derived: sum of 3 quarters · filed 2025-08-07 | $608.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $115.00K 10-Q · filed 2025-05-13 | $418.00K derived: sum of 2 quarters · filed 2025-05-13 | $514.00K derived: sum of 3 quarters · filed 2025-11-12 | $714.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $399.00K derived: sum of 2 quarters · filed 2025-11-12 | $599.00K derived: sum of 3 quarters · filed 2025-11-12 | $1.07M 10-K · filed 2025-03-31 |
| 2024-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $296.00K derived: sum of 2 quarters · filed 2025-11-12 | $768.00K 10-Q · filed 2025-11-12 | $1.28M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $672.00K 10-Q · filed 2025-08-07 | $1.19M derived: sum of 3 quarters · filed 2025-08-07 | $1.75M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $472.00K 10-Q · filed 2025-05-13 | $989.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.55M derived: sum of 3 quarters · filed 2025-05-13 | $1.46M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.08M derived: sum of 2 quarters · filed 2025-03-31 | $983.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.73M 10-K · filed 2025-03-31 |
| 2023-09-30 | $563.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $466.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.22M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $653.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $750.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $920.00K 10-K · filed 2024-04-01 |